Induction of Ischemic Tolerance Protects the Retina From Diabetic Retinopathy

• Published in: The American journal of pathology Vol. 178; no. 5; pp. 2264 - 2274
• Main Authors: Fernandez, Diego C, Sande, Pablo H, Chianelli, Mónica S, Aldana Marcos, Hernán J, Rosenstein, Ruth E
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Elsevier Inc 01.05.2011; American Society for Investigative Pathology
• Subjects: Animals; Biological and medical sciences; Blood-Retinal Barrier - pathology; Blotting, Western; Diabetes Mellitus, Experimental - complications; Diabetes Mellitus, Experimental - pathology; Diabetes. Impaired glucose tolerance; Diabetic Retinopathy - pathology; Diabetic Retinopathy - prevention & control; Electroretinography; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Immunohistochemistry; Investigative techniques, diagnostic techniques (general aspects); Ischemic Preconditioning - methods; Male; Medical sciences; Microscopy, Electron, Transmission; Ophthalmology; Pathology; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques; Rats; Rats, Wistar; Regular; Retinopathies; Endocrinopathy; Retinopathy; Induction; Diabetes mellitus; Tolerance; Cardiovascular disease; Retina; Eye; Visual system; Eye disease; Anatomic pathology; Ischemia; Protection
• ISSN: 0002-9440; 1525-2191
• DOI: 10.1016/j.ajpath.2011.01.040

Diabetic retinopathy is a leading cause of acquired blindness. Available treatments are not very effective. We investigated the effect of a weekly application of retinal ischemia pulses (ischemic conditioning) on retinal damage induced by experimental diabetes. Diabetes was induced by an intraperitoneal injection of streptozotocin. Retinal ischemia was induced by increasing intraocular pressure to 120 mmHg for 5 minutes; this maneuver started 3 days after streptozotocin injection and was weekly repeated in one eye, whereas the contralateral eye was submitted to a sham procedure. Diabetic retinopathy was evaluated in terms of i) retinal function (electroretinogram and oscillatory potentials), ii) integrity of blood-retinal barrier (by albumin–Evans blue complex leakage and astrocyte glial fibrillary acidic protein IHC), iii) optical and electron microscopy histopathologic studies, and iv) vascular endothelial growth factor levels (using Western blot analysis and IHC). Brief ischemia pulses significantly preserved electroretinogram a- and b-wave and oscillatory potentials, avoided albumin–Evans blue leakage, prevented the decrease in astrocyte glial fibrillary acidic protein levels, reduced the appearance of retinal edemas, and prevented the increase in vascular endothelial growth factor levels induced by experimental diabetes. When the application of ischemia pulses started 6 weeks after diabetes onset, retinal function was significantly preserved. These results indicate that induction of ischemic tolerance could constitute a fertile avenue for the development of new therapeutic strategies for diabetic retinopathy treatment.